Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for the Prophylactic Treatment of Migraine
NCT03972124Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Zygel in chronic migraine, sponsored by University of Calgary. Started Apr 2026; status: recruiting.
02
Drugs
Zygel
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03972124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03972124.